We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




FDA Clears Vertebral Body Replacement Device

By HospiMedica staff writers
Posted on 26 Jan 2001
A vertebral body replacement (VBR) device has been cleared by the U.S. More...
Food and Drug Administration (FDA) for use in the thoracolumbar spine to replace a collapsed, damaged, or unstable vertebral body due to tumor or trauma (i.e. fracture).

The VBR device is manufactured by Ulrich GmbH & Co. (Ulm, Germany). The company believes this is the first time the FDA has specifically cleared any single device for these indications. The system is unique because of its adjustable length feature and its ability to restore biomechanical integrity to the injured spinal column and correct angular deformity without additional external distractors or spreaders. VBR is distributed by Ulrich in all countries except the United States and Canada, where it is distributed by Osteotech (Eatontown, NJ, USA).

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Imaging Table
Stille imagiQ2
External Defibrillator
HeartSave Y | YA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.